Sign inJoin waitlistJoin the waitlist

Andreas Saltos

Physician · H. Lee Moffitt Cancer Center and Research Institute

Credentials: · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
Present

H. Lee Moffitt Cancer Center and Research Institute
2015–2017
Internal Medicine
University of Maryland, Baltimore
2012–2015
University of Maryland School of Medicine
2008–2012

Research

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2022 · 868 citations
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Nature Medicine · 2021 · 374 citations
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Nature · 2024 · 178 citations

Jhanelle Gray
16 papers
Alberto Chiappori
10 papers
Ben Creelan
10 papers
Eric Haura
10 papers
Scott Antonia
9 papers
Tawee Tanvetyanon
9 papers
Michael Shafique
7 papers
Bradford Perez
5 papers
Theresa Boyle
5 papers
Trevor Rose
4 papers
Xiuning Le
4 papers
JS
James Saller
3 papers

Clinical trials

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Principal investigator · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2026–2027
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Principal investigator · Recruiting · Phase 1
Memgen, Inc.
2022–2031
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
Principal investigator · Active not recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2019–2027
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
2026–2028